{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:25:45Z","timestamp":1738387545602,"version":"3.35.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>CONTEXT:<\/jats:title>\n            <jats:p>COVID-19 has been associated with features of a cytokine storm syndrome with some patients sharing features with the hyperinflammatory disorder, secondary hemophagocytic lymphohistiocytosis (sHLH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>HYPOTHESIS:<\/jats:title>\n            <jats:p>We hypothesized that proteins associated with sHLH from other causes will be associated with COVID-sHLH and that subjects with fatal COVID-sHLH would have defects in immune-related pathways.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS AND MODELS:<\/jats:title>\n            <jats:p>We identified two cohorts of adult patients presenting with COVID-19 at two tertiary care hospitals in Seattle, Washington in 2020 and 2021. In this observational study, we assessed clinical laboratory values and plasma proteomics. Subjects identified as having sHLH (ferritin &gt; 1000 plus cytopenias in two or more lineages [WBC &lt; 5000 odds ratio [OR] ANC (absolute neutrophil count) &lt; 1000, hemoglobin &lt; 9 or hematocrit &lt; 27, platelets &lt; 100,000], and elevated transaminases [either AST (aspartate aminotransferase) or ALT (alanine aminotransferase) &gt; 30] OR subjects with a ferritin &gt; 3000) were compared with those with COVID-19 without sHLH. We identified 264 patients with COVID-19 of whom 24 met our sHLH definition. Eight patients who died of COVID-sHLH underwent genomic sequencing to identify variants in immune-related genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Nine percent of enrolled COVID-19 subjects met our defined criteria for sHLH (<jats:italic toggle=\"yes\">n<\/jats:italic> = 24\/264). Using broad serum proteomic approaches (O-link and SomaScan), we identified three proteins increased in subjects with COVID-19-associated sHLH (soluble PD-L1 [sPD-L1], tumor necrosis factor-R1, and interleukin [IL]-18BP, <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.05 for O-link and false discovery rate &lt; 0.05 for SomaScan), supporting a role for proteins previously associated with other forms of sHLH (IL-18BP and soluble tumor necrosis factor receptor 1). We also identified candidate proteins and pathways associated with COVID-sHLH, including sPD-L1 and the syntaxin pathway. We detected pathogenic variants in <jats:italic toggle=\"yes\">DOCK8<\/jats:italic> and <jats:italic toggle=\"yes\">TMPRSS15<\/jats:italic> in deceased individuals with COVID-sHLH, further suggesting that alterations in immune-related processes may contribute to hyperinflammation and fatal outcomes in COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERPRETATIONS AND CONCLUSIONS:<\/jats:title>\n            <jats:p>Proteins increased in COVID-19-associated sHLH, such as sPD-L1, and pathways, such as the syntaxin pathway, suggest important roles for the immune response in driving sHLH in the context of COVID-19.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001203","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:00:56Z","timestamp":1738342856000},"page":"e1203","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Proteomic Analyses in COVID-19-Associated Secondary Hemophagocytic Lymphohistiocytosis"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1762-6718","authenticated-orcid":false,"given":"Susan P.","family":"Canny","sequence":"first","affiliation":[{"name":"Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA."},{"name":"Department of Pediatrics, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian B.","family":"Stanaway","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kidney Research Institute, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Holton","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA."},{"name":"Center for Translational Immunology, Benaroya Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallorie","family":"Mitchem","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, Benaroya Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison R.","family":"O\u2019Rourke","sequence":"additional","affiliation":[{"name":"Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Pribitzer","sequence":"additional","affiliation":[{"name":"Center for Systems Immunology, Benaroya Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Baxter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, WA."},{"name":"Sonoma Biotherapeutics, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark M.","family":"Wurfel","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Virginia Mason Medical Center, Seattle, WA."},{"name":"Department of Medicine, Section of Infectious Diseases, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane H.","family":"Buckner","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, Benaroya Research Institute, Seattle, WA."},{"name":"Department of Immunology, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan K.","family":"Bhatraju","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Morrell","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cate","family":"Speake","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Mikacenic","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA."},{"name":"Center for Translational Immunology, Benaroya Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5864-5299","authenticated-orcid":false,"given":"Jessica A.","family":"Hamerman","sequence":"additional","affiliation":[{"name":"Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA."},{"name":"Department of Immunology, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2021.03.002","article-title":"COVID-19 and cytokine storm syndrome: Are there lessons from macrophage activation syndrome?","volume":"232","author":"Ombrello","year":"2021","journal-title":"Transl Res"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"102567","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10067-020-05569-4","article-title":"Haemophagocytic syndrome and COVID-19.","volume":"40","author":"Retamozo","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: A cohort study.","volume":"2","author":"Webb","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"e143648","DOI":"10.1172\/JCI143648","article-title":"The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.","volume":"131","author":"Bolouri","year":"2021","journal-title":"J Clin Invest"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm.","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European League against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19.","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","article-title":"Plasma protein patterns as comprehensive indicators of health.","volume":"25","author":"Williams","year":"2019","journal-title":"Nat Med"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"eabi4888","DOI":"10.1126\/scitranslmed.abi4888","article-title":"Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity.","volume":"14","author":"Lambert","year":"2022","journal-title":"Sci Transl Med"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19.","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.13026","article-title":"Characteristic elevation of soluble TNF receptor II: I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.","volume":"191","author":"Shimizu","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome.","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"e27909","DOI":"10.1002\/pbc.27909","article-title":"CD163 as a valuable diagnostic and prognostic biomarker of sepsis-associated hemophagocytic lymphohistiocytosis in critically ill children.","volume":"66","author":"Cui","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0961203319860201","article-title":"Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.","volume":"28","author":"Nishino","year":"2019","journal-title":"Lupus"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis.","volume":"135","author":"Canna","year":"2020","journal-title":"Blood"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"key":"R20-20250131","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"key":"R21-20250131","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells.","volume":"119","author":"Cote","year":"2009","journal-title":"J Clin Invest"},{"key":"R22-20250131","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"R23-20250131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13073-023-01173-8","article-title":"Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.","volume":"15","author":"Matuozzo","year":"2023","journal-title":"Genome Med"},{"key":"R24-20250131","doi-asserted-by":"crossref","first-page":"eabl4348","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.","volume":"6","author":"Asano","year":"2021","journal-title":"Sci Immunol"},{"key":"R25-20250131","doi-asserted-by":"crossref","first-page":"e20220170","DOI":"10.1084\/jem.20220170","article-title":"Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia.","volume":"220","author":"Garcia-Garcia","year":"2023","journal-title":"J Exp Med"},{"key":"R26-20250131","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19.","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"R27-20250131","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression.","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"key":"R28-20250131","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.4049\/jimmunol.167.12.7038","article-title":"Expression and release of IL-18 binding protein in response to IFN-gamma.","volume":"167","author":"Paulukat","year":"2001","journal-title":"J Immunol"},{"key":"R29-20250131","doi-asserted-by":"crossref","first-page":"695242","DOI":"10.3389\/fimmu.2021.695242","article-title":"PD-L1 dysregulation in COVID-19 patients.","volume":"12","author":"Sabbatino","year":"2021","journal-title":"Front Immunol"},{"key":"R30-20250131","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/biom12030445","article-title":"Circulating levels of PD-L1, TIM-3 and MMP-7 are promising biomarkers to differentiate COVID-19 patients that require invasive mechanical ventilation.","volume":"12","author":"Chavez-Galan","year":"2022","journal-title":"Biomolecules"},{"key":"R31-20250131","doi-asserted-by":"crossref","first-page":"L14","DOI":"10.1152\/ajplung.00049.2022","article-title":"Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.","volume":"323","author":"Morrell","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R32-20250131","doi-asserted-by":"crossref","first-page":"592727","DOI":"10.3389\/fimmu.2021.592727","article-title":"Increased serum levels of soluble TNF-alpha receptor is associated with ICU mortality in COVID-19 patients.","volume":"12","author":"Mortaz","year":"2021","journal-title":"Front Immunol"},{"key":"R33-20250131","doi-asserted-by":"crossref","first-page":"e0275745","DOI":"10.1371\/journal.pone.0275745","article-title":"Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients.","volume":"17","author":"Gohda","year":"2022","journal-title":"PLoS One"},{"key":"R34-20250131","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.41763","article-title":"Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes using disease-related blood biomarkers.","volume":"73","author":"Kessel","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R35-20250131","doi-asserted-by":"crossref","first-page":"777851","DOI":"10.3389\/fimmu.2021.777851","article-title":"Digenic inheritance: evidence and gaps in hemophagocytic lymphohistiocytosis.","volume":"12","author":"Steen","year":"2021","journal-title":"Front Immunol"},{"key":"R36-20250131","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.3390\/diagnostics12112789","article-title":"Proteomic analysis of pleural effusions from COVID-19 deceased patients: Enhanced inflammatory markers.","volume":"12","author":"Razaghi","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R37-20250131","first-page":"417","article-title":"Hemophagocytic lymphohistiocytosis gene variants in multisystem inflammatory syndrome in children.","volume":"11","author":"Vagrecha","year":"2022","journal-title":"Biology (Basel)"},{"key":"R38-20250131","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1111\/1462-2920.16028","article-title":"Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.","volume":"24","author":"Grenga","year":"2022","journal-title":"Environ Microbiol"},{"key":"R39-20250131","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.3324\/haematol.2020.260307","article-title":"Perforin gene variant A91V in young patients with severe COVID-19.","volume":"105","author":"Cabrera-Marante","year":"2020","journal-title":"Haematologica"},{"key":"R40-20250131","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41431-021-00886-x","article-title":"Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms.","volume":"29","author":"Luo","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"R41-20250131","first-page":"149","article-title":"A rare STXBP2 mutation in severe COVID-19 and secondary cytokine storm syndrome.","volume":"12","author":"Reiff","year":"2022","journal-title":"Life (Basel)"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:01:07Z","timestamp":1738342867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001203","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}